News – Page 3 – www.brainwork.md

12th October 2018

Fighting neurodegeneration in MS

https://www.brainwork.md/content/uploads/2018/10/Brainwork-FightingNeurodegeneration.jpg 3150 2100 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 12th October 2018 12th October 2018

The pathology of multiple sclerosis (MS) involves not only the loss of myelin sheets around the axons of neurons, but also the fragmentation of the axons themselves. At ECTRIMS 2018,…

Mea Holm, PhD
0
0

12th October 2018

MS treatment strategy: Hitting hard and early, or minimising risks through stepwise escalation?

https://www.brainwork.md/content/uploads/2018/10/Brainwork-MSTreatmentStrategy-e1540300616685.jpg 1969 1525 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 12th October 2018 12th October 2018

With more than a dozen approved treatment options for relapsing-remitting multiple sclerosis (RRMS), treatment decision making is an increasingly complex task for neurologists. At ECTRIMS 2018, the topic on which…

Mea Holm, PhD
2
0

11th October 2018

FLOODLIGHT offers illuminating outcomes for smartphone monitoring in MS

https://www.brainwork.md/content/uploads/2018/10/MPR425-Brainwork-illustrations-articles-Floodlight-V00-01-20181011-01-1.jpg 1920 1080 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 11th October 2018 11th October 2018

Smartphone-based, high-yield active and passive self-monitoring of multiple sclerosis (MS) may enhance clinical disease assessments when compared to conventional methods for detecting subtle progressive clinical changes, according to a study…

Peter Stevenson, PhD
1
0

5th October 2018

New molecule could halt neural damage in Parkinson’s disease

https://www.brainwork.md/content/uploads/2018/10/Brainwork-NewMoleculeCouldHalt.jpg 2967 1980 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 5th October 2018 5th October 2018

Researchers may have found a way to halt, and even reverse, the neural damage associated with Parkinson’s disease (PD) using a novel molecule that targets a key cause of nerve…

Peter Stevenson, PhD
0
0

1st October 2018

Restoring “conductor” cells in the orchestra of schizophrenia

https://www.brainwork.md/content/uploads/2018/10/Brainwork-Orchestra.jpg 2850 1900 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 1st October 2018 1st October 2018

Key symptoms of schizophrenia, including hallucinations, hyperactivity and impaired memory, could be caused by desynchronised cells in the brain, recent research published in Nature Neuroscience has revealed. The authors investigated…

Peter Stevenson, PhD
0
1

28th September 2018

3 minutes with Prof. Goadsby – Interview from SNG

https://www.brainwork.md/content/themes/anemos/images/empty/thumbnail.jpg 150 150 Rachel Park, MA Rachel Park, MA https://secure.gravatar.com/avatar/4ebf9310e1faab0e0e0630445cf726cb?s=96&d=mm&r=g 28th September 2018 28th September 2018

Professor Peter Sandor interviewed Professor Peter Goadsby at the SNG Annual Meeting this week in Montreux, Switzerland. They spoke about one of the top leading causes of disability–migraine. Watch the…

Rachel Park, MA
0
1

27th September 2018

Paralysis patients able to walk after epidural stimulation

https://www.brainwork.md/content/uploads/2018/09/Brainwork-ParalysisPatientsAbletoWalk.jpg 3016 1900 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 27th September 2018 27th September 2018

Patients with complete lower limb paralysis after spinal cord injury (SCI) have been given the ability to walk again, it was reported this week. In work published in Nature Medicine,…

Peter Stevenson, PhD
0
0

19th September 2018

Quarterly migraine injection approved in US

https://www.brainwork.md/content/uploads/2018/09/Brainwork-FDAApprovesMigraine.jpg 2885 1900 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 19th September 2018 19th September 2018

The US FDA has approved a new humanised monoclonal antibody for migraine prevention in adults. Fremanezumab-vfrm – under the brand name AJOVYTM (Teva Pharmaceuticals) – prevents the interaction between calcitonin…

Peter Stevenson, PhD
1
0

17th September 2018

Gut feelings on MS: A conversation with Prof. Pot

https://www.brainwork.md/content/uploads/2018/09/Caroline-Pot-Kreis_DSC1941-1.jpg 2359 1740 Mea Holm, PhD Mea Holm, PhD https://secure.gravatar.com/avatar/7a927c1dcef51229f6403ce27328c69e?s=96&d=mm&r=g 17th September 2018 17th September 2018

How does the gut–brain axis influence neuro-inflammation and the disease course of MS? Although we know that gut homeostasis and gut functions are closely related to food intake, we want…

Mea Holm, PhD
0
0

12th September 2018

Autism blood test could be just around the corner

https://www.brainwork.md/content/uploads/2018/09/Brainwork-AutismBloodTest.jpg 2846 1900 Peter Stevenson, PhD Peter Stevenson, PhD https://secure.gravatar.com/avatar/c5331bc85b1dc3f9749cac7354ddaaad?s=96&d=mm&r=g 12th September 2018 12th September 2018

A link between autism spectrum disorder (ASD) and the dysregulation of amino acids has been identified, thereby promoting more evidence for the use of metabolic testing for earlier identification and…

Peter Stevenson, PhD
0
0